Clinical trial
A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With…
NCT00277043 · New Mexico Cancer Research Alliance, Other · Completed
Key facts
| NCT number | NCT00277043 |
|---|---|
| Title | A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes |
| Official title | A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes |
| Lead sponsor | New Mexico Cancer Research Alliance, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Supportive, Ill-defined Sites |
| Intervention type | Drug |
| Interventions | paclitaxel, docetaxel, taxane |
| Enrollment | 200 |
| Start date | Jun 1, 2002 |
| Primary completion | Jul 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Jan 13, 2006 |
| Last update posted | Sep 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: